Vaccination

ID is a dynamic field that is constantly changing. The types of infections we’re talking about today are different than what we may have been talking about 5 years ago. So, it’s intellectually stimulating and challenging.

Researchers developed a low-cost rapid test to detect an invasive species of mosquito that has adapted to live near humans in urban environments, which they hope can be used in areas far from medical labs.

Throughout the course of human history, one infectious disease (Figure 1) may account for more deaths than any other, perhaps all others combined.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to control the deadly mosquito-borne disease.

The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case.

The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.